Morphic Holding, Inc. Collaboration Agreements
9 Contracts & Agreements
- Amendment No. 2 to Research Collaboration and Option Agreement, dated as of June 18, 2021, by and between the Registrant and Janssen Pharmaceuticals, Inc (Filed With SEC on August 4, 2021)
- Amendment No. 1 to the Research Collaboration and Option Agreement, dated December 30, 2020, by and among Janssen Pharmaceuticals, Inc. and the Registrant (Filed With SEC on March 1, 2021)
- Collaboration and Option Agreement, dated October 16, 2018, by and between AbbVie Biotechnology Ltd and the Registrant (Filed With SEC on June 24, 2019)
- Collaboration and Option Agreement, dated October 16, 2018, by and between AbbVie Biotechnology Ltd and the Registrant (Filed With SEC on June 14, 2019)
- Research Collaboration and Option Agreement, dated February 15, 2019, by and among Janssen Pharmaceuticals, Inc. and the Registrant (Filed With SEC on June 14, 2019)
- Collaboration Agreement, dated June 10, 2015, by and between Morphic Rock Therapeutic, Inc. and Schrdinger, LLC, as amended (Filed With SEC on June 14, 2019)
- Collaboration and Option Agreement, dated October 16, 2018, by and between AbbVie Biotechnology Ltd and the Registrant (Filed With SEC on May 30, 2019)
- Research Collaboration and Option Agreement, dated February 15, 2019, by and among Janssen Pharmaceuticals, Inc. and the Registrant (Filed With SEC on May 30, 2019)
- Collaboration Agreement, dated June 10, 2015, by and between Morphic Rock Therapeutic, Inc. and Schrdinger, LLC, as amended (Filed With SEC on May 30, 2019)
